KOLESNIK, O. P.; KUZMENKO, V. O. ERCC1 as a marker of prognosis and sensitivity to platinum-based chemotherapy in patients with stage III–IV non-small cell lung cancer. Pathologia, [S. l.], n. 1, 2020. DOI: 10.14739/2310-1237.2020.1.203639. Disponível em: http://pat.zsmu.edu.ua/article/view/203639. Acesso em: 8 may. 2024.